Chief Executive Officer
Ten63 Therapeutics
North Carolina
Marcel Frenkel serves as Chief Executive Officer at Ten63 Therapeutics. Ten63 Therapeutics operates in the research sector with approximately 25.0 employees. The company is headquartered in North Carolina. Ten63 Therapeutics generates annual revenue of 1250000.0. To date, Ten63 Therapeutics has raised 18049981.0 in total funding, with the most recent round being Series A.
Executives like Marcel Frenkel in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Ten63 Therapeutics.
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.
Marcel Frenkel's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at Ten63 Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.
Marcel Frenkel is Chief Executive Officer at Ten63 Therapeutics, a company in the research sector with 25.0 employees. The company is based in North Carolina.
As Chief Executive Officer at Ten63 Therapeutics, Marcel Frenkel is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Marcel Frenkel directly — ideal for B2B sales, partnerships, and executive recruiting.
Marcel Frenkel works in the research industry as Chief Executive Officer at Ten63 Therapeutics. MessageCEO provides verified contact information for executives across all major industries.
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Marcel Frenkel's profile is kept up-to-date with the latest available information.